Join us for this free, accredited educational activity.
Dr. Ilana Halperin, Sunnybrook Health Sciences Center, University of Toronto
Monday, March 22, 2021
First presentation: 12:00-1:00pm Eastern Time
Second presentation: 5:00-6:00pm Eastern Time
- Review the 2020 Diabetes Canada Update on Pharmacotherapy for Type 2 Diabetes with a focus on the non-glycemic benefits of newer agents.
- Identify indications for diabetes medications in non-diabetes populations.
- Become familiar with advanced technologies in diabetes management.
The live online session Diabetes Update is an educational activity approved as an Accredited Group Learning Activity under Section 1 of the Framework of Continuing Professional Development options as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. As an accredited provider, CSIM has approved this program for 1 credit hour.
- View faculty and planning committee conflict of interest disclosures.
- Physicians should only claim credit commensurate with the extent of their participation in the activities.
- Claim your MOC credits at the Royal College of Physicians and Surgeons of Canada Mainport site.
About Dr. Ilana Halperin
Dr. Ilana Halperin is an Endocrinologist at Sunnybrook Health Sciences Center and an assistant professor at the University of Toronto. She received her BSC at McGill, her MD at Western and did her Internal Medicine and Endocirnology training at The University of Toronto. She also has a Masters in Quality Improvement and Patient Safety from the Institute for Health Policy, Management and Evaluation at UofT. She was an early adopter of virtual care even before the pandemic and was recently appointed as the physician lead for digital health and virtual care at Sunnybrook. She has presented on the role of virtual care generally and specifically for the diabetes population locally, provincially and nationally. While she cares for all people with diabetes she is especially passionate about caring for young adults and pregnant women with Type 1 diabetes.